Lisata Therapeutics Inc. (NASDAQ: LSTA)
$3.72
+0.0200 ( +0.54% ) 2.5K
Lisata Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapies for the treatment of advanced solid tumors and other major diseases. Its product candidate, LSTA1, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively.
Market Data
Open
$3.72
Previous close
$3.70
Volume
2.5K
Market cap
$29.99M
Day range
$3.63 - $3.70
52 week range
$1.95 - $3.87
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 13 | Jun 27, 2024 |
10-q | Quarterly Reports | 82 | May 09, 2024 |
8-k | 8K-related | 68 | May 09, 2024 |
def | Proxies and info statements | 7 | Apr 29, 2024 |
3 | Insider transactions | 2 | Apr 24, 2024 |
8-k | 8K-related | 13 | Apr 17, 2024 |
ars | Annual reports | 1 | Mar 28, 2024 |
10-k | Annual reports | 227 | Feb 29, 2024 |
8-k | 8K-related | 67 | Feb 29, 2024 |
4 | Insider transactions | 1 | Jan 12, 2024 |